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Abstract
11/h exarrnhed treairr rv patterns of female ots re/tn
COP i ,ipedforaCc m ‘s ret Os c cc cues
200 patients with chronic kidney dOease presenting
with acute coronary syndrome, we found that females
patients were less like/v to receive asoirin and ACE
,nhhiPrs and there• toarc..less frequent
use of coronary an cc so co V
Introduction
Coronary heart disease C! ID) continues to be the lead
ing cause of morbidity and mortalit\ among persons
in industrialized countries, In addition, patients a ith
chronic kidney disease (CKD) have a high prevalence
of cardiovascular disease and cardiac death. In the
United States, cardiac disease accounts for 44% of
overall mortality in chronic dialysis patients. Recent
data support the application of pros en interventions
n the general population. such as :iitgioleil sin—eon—
citing enzyme inhibitors and stauns to patients with
(IKE) and ESRD.—- ‘ Each year more than I million
American women and men are diagnosed wtth acute
mvocardial infhrctiont\Ml Prc-s ous studies looking
at sex difl2rences in management of acute coronar\
syndromes (ACS) found that women were less likel5
to undergo more ir.vasive t.reatments than m.en.4-1/’
Other studies also report that women a.re i.ess iikei.y
to undergo both diagnostic and rsmaseularization
procedures than men. -‘
There is a lack ofdata e\ aluatino vender di tfdrenees
in the management ot\( S in patients th CK[). The
purpose of’this studs s tO evaluate vender differences
a I reritment patterns o tpat ems th ( K I) resenti no
Methods
.Denaogra.phi.c and. clini.cal data were extracted as
specified in the results section. Bleeding was defined
as edher minor or nior bleeding epsude following
the F! \i I bleeding entena reference. We e/itevorlted
participants into two n/Lips based on the existence
of chronic renal lailure. \ormall distributed data is
reported as mean and standard deviation iSD i. non—
normally data is presented as median and interquartile
range. Characteristics between the two groups were
compared by Chi-Square for dichotomous variables
and Mann-Whitney U Test and Student’s I-test for
continuous x ariables, To determine the independent
association between incidence ot bleeding and other
eofactnrs including CKD ‘se used binary logistic re
gression analr sO to calculate odds ratios The study
was a retrospectis e analysis of patients a ith CKD
svlio presented to two major hospitals in the metro
politan area of Honolulu, Hasvai i from ,Tanuarv 2001
to June 2003. Patients caring an lCD 9 code for
ACS and CKI) as a primary or secondary diagnosis
were included.
Patients with a Creatinine less than 1.5 a crc ex
cluded from the study. Criteria for diavnosis of ST
segment des anon AM! includes isehemic-is pe chest
discomfort of r-30 minutes a oh electrocardiogram
evidence ofST-segrnent des ation >0.2 niV ni *2 con
tiguous preeordial leads ot’ST—segnient des anon --0.
mY in >2 limb leads and an elevated serum creatine
kinase-MB level (>1 0%)oran elevated serum cardiac-
specific troponin I level (>2 ng ml). Non-ST-segment
elevation ACM was diagnosed by ischemic-tvpe chest
discomfort of aSflminuteses ithout ST-segment eleva
tion butwith an des ated serum creatinekinasc-M13 or
a cardiac-specific troponin 1 level Unstable anina
was diasznoed by schcmic-t pc chest discomiort ot
minutes with nonnal serum c reatinek nasc-Ml3
and cardiac-specitic troponin levels. Data on demo
graphics,e rirdrae risk factors, presenting 51 mptoins,
diagnosti.c. tests an.d therapeutic interventions were
athered front the patient’s medical records:. Killip
cl.assii.lcation wa.s d.efined using. the coil.ected data in.
order to assess symptoms of heart fttilure. Statistical
analyses svas done usine chi-square, Student’s t-tdSt
and Mann-\\ hitne\ U test to determie differences
n rn/ma ement bctsveeu the t\\ o treatment ioups.
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Table 1.— Baseline Characteristics for Women and Men
Variable Women m=97:’ Men 1n104i Pvalue
Age (years) [mean ± SDI 68 ± 13.8 70 ± 2.8 NS
Comorbidties (%1
Pevous myocarda! .n.tarcton 2.3 39.4 NS
Previous PCI 15.5 9.6 NS
Previous CARG 26.8 27.9 NS
Hypertension 89] 86.5 NS
Diabetes 67.0 43.3 NS
Hyper!ioioema 3.3 365 NS
Obesity’ 2.2 7] NS
Smokng 5.2 rO,6 NS
FamiIy history of CAD 25,8 14.4 0.044
Troponin max (ngimL
MeCian [rnterquarile_range] 2.3 [0.2619.77] 2] [0.2’7.6.75] NS
Creatinne knase-MB man UL
Median [interquartile range] 8.4 [3.618,8] 8.3 [4,720.8] NS
LV ejection fraction
Mean ± SD 45°c ± 16.6 42% ± 14.3 NS
Kilhp class i%)
I 36.1 50 0.03
II 38.1 33.7 NS
III 25.8 14.4 0.044
IV 0 2.3 NS
Abbreviations: CABG. coronary artery bypass graft: CAD. coronary artery disease: PCi. percutaneous coronary intervention: LV i.eft ventrcu(ar
‘Obesity defined as BMI25.
Results
The studs’ included 97 women, mean age 08 ± 14
years (range 35 to 981. and 104 men. mean age ‘70 ±
13 years (range 29 to 100) (p—\ S>. Table 1 shows the
prevalence of coronary risk kiciors in women versus
men, Family history of coronary artery disease was
statistically more prevalent in women (25.8%) than
men (14.40 o’ (p=O.44). There was no statistically
significant difference in seeritv of disease between
women and men, Both groups presented with similar
maximum serum creatine kinase-MB and cardiac spe
cific troponin 1. In addition, both men and women had
similar left ventricular ejection fractions, However.
women tended to present with worse Killip classifica
tion than men. (Table H
There were no significant differences in the rates
of non—in asive testing. Both women and men had
similarrates oflipid panel evaluation and stress testing
[able 2) Dcspite thsc dttfei.nccs in stlLsS testin,
rates, women were less likely to undergo coronary
angiographv. Aspirin and ACE—inhibitors \ crc used
signiticantlv less frequently in women compared to
men. In contrast to these findings, more women were
treated with ARBs, (Table 2) The rates of PCI and
CABU were similar across both gender groups.
Discussion
Previous studies that assessed gender differences in
i\CS within the normal population found that women
were older than men and had more risk factors and
more cornorbid conditions.4 ,12,1.’ Our stud found
no age differences between women and men with
CKD presenting with ACS. nor were there more risk
factors or comorhidities. Despite women presenting
with orsc svnxptoms of heart failure, this study
found that women with C’KD presenting sith ACS
were less likely to recci’ c aspirin and ACE inhibi
tors compared to men. Our findings are consistent
1. •.., .•:1[. 6?, NOOFI00.:2 2001
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Table 2.— Diannosis and Treatment of Acute Coronary Syndrome in Chronic Renal Failure
Reperluson therapy
PCI 14,4 115 NS
CABG 6.2 9.6 NS
Abbreviat:o’s’ ACE. angotenvinogen convertng enzyme: ARE. angiotenan receptor blocker: CABS coronary artery bypass graft: PCI. percutaneous coronary ntervention.
Variable Women (n=97) Men (n=104) P value
Ncn-’vasve 1est:ng
I’v.’as’e tes:na
NS
NS
L
39e I 3.058
Iviedicatron
Liprds
Stress test
AnaioaraOhv
ACE inhrhtor
ARB
Asprirn
Betablocker
Clopidogrel
Enoxapann
GPllbllla
IV Heparin
Nitropaste
Stalin
26.8
37
37
69
71
36
24
8.3
20.6
51
52
53
20
83
72
34
32
6.7
15.3
48
58
0.025
0.008
0.041
NS
NS
NS
NS
NS
NS
NS
vv ith prey ions studies looking at gender differences
in patients presenting with ACS. These studies found
that \VonlCn were less likely to be treated with aspirin.
heparin. or hera-blockers. In contrast to our study’,
these previous studies did not look specifically at
patients with CKD. Based on our results we are un
able to explain why there is a difference between the
treatment of men and women presenting with ACS.
Possible explanations include a lack of knowledge of
how prevalent heart disease is in women and a lack
of emphasis (‘If treating heart disease in women as
compai’ed to men. Further larger studies are needed
tO (Icterinlite how significant a di lYerencc there is
between cenders and why this occurs. Ut particular
interest vu ould he what impact thi’ decreased use of
Ilierap for A(’S has on outcomes among the female
popu at ion present ne vu 1 th AC’ S.
In addition todil’trences in medical therap\ between
men and vu omen. our study found a decreased utiiiia
tiun ot eownarc ancuocraphy in the fiuinale population.
These indinurs are similar to p ions research that
bond that vu omeit iii all age croups vu crc less likely
to undera’o dtagttosttc catheteritation than men.’ in
addition. prey tous studies have found that womett
were less likely’ to undergo more aggressive diagtiostic
evaluation and treatment than men. Reasotys for
treatment di ITi.rrenccs hetvv een men and women ma\
include a bias towards more cotlservatix e thcrap in
the female population or an under estimation of how
large an impact heart disease has’ on this gender group.
Further larger studies are needed to determine how
sinificant a difference there is between genders and
why this occurs.
Harrold et al, examined gender differences and
trends’ over tinte in the management of patients with
AMI.4These mu estigators noted that overall. vu omen
were less likel\ to undergo cardiac PCI and CARCi.
In this study, how ever, there was no significant
difference between rev ascularization rates among
both ei’oups. Possible reason for die difference in
our tndtngs compared to other studies mau’ be the
ox’et’all buy incidence ol C; KD pateiits undergoinc
revaseulariiatIon secotldarv to eomorhidities.
Inureneralthis’tudv foundthatpatientswith(’KDare
less lkeiy to urideruto revascularization compared to
patients w ithout renal insufticieney. This is consistent
with prey ions studies uvl’tmch found that patcilts vu ith
C kD presenting vu ith A(’S receive less aggressive
treatment.’ , ‘ Perhaps patients with C KI) man tan e
tilore eontraitldieations to aspirin, beta—blockers, and
ACE inhibitors. In addition, patients with CKI) may
have poorer outcome after interventional thet’ap\.
::,((,,Ji ME::D:C’.A:,,JouF’NAu,, vo:,,,, 63. NOVEMBER 20(4
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There were several limitations inherent in this study.
This study was a small, retrospective, observational,
chart review study done at 2 metropolitan Honolulu
hospitals, and therefore may not be representative of
other hospitals nationwide. In addition, as a retrospec
tive study there is the potential for referral bias.
Conclusions
ThL rHsults of t is study dcmo strat d that il hou oh
s 0 i n ‘a ith CKD ha I similai hasLh , L ai 8 te istic
compared torn n wilh C’KD at Orne o p snt’ttion for
ACS s ornLn rc t v. tt d lt,ss a ressic v Women
C kss hkdy to ccci C tsptrrn and s o alua I
‘a ith cardia. cathcri ation 1 ss oft n than men
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to need regular
Pap tests.
National Cancer
institute1s Cancer
information Service
at 1-800-4-CANCER
equipment, dial
Par
Pap tests can help
find cervical cancer
at an early stage
while itS still easier
to cure.
You’re never too old
Questions about
the Pap test? Ask your
doctor or call the
(1-800-422-6237).
1-800-332-8615.
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